Diabetes Drugs Examined for Benefits, Risks to Heart Health

Metformin may have advantages over other commonly used diabetes medications, according to recent research.

In a recent study comparing the effectiveness of sulfonylureas and metformin as first-line treatments of diabetes, metformin was associated with more positive outcomes. The study, published recently in the Annals of Internal Medicine, found that sulfonylureas were associated with a 21 percent increased risk for acute myocardial infarction (heart attack), stroke or death compared to metformin.
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access